09-05-2008: The EU Commission held a debate on the biotech crop approval process in Europe and sent out a disappointing signal when it agreed to send back three cultivation dossiers which had been positively assessed. Europe is already lagging behind worldwide competition when it comes to biotech crops: more than 40 products are awaiting EU approval. Furthermore, in the light of the current bottlenecks in the supply of food and feed, ,according to EuropaBio, it is unacceptable to keep putting off decisions by asking the European Food Safety Authority (EFSA) to reconsider dossiers such as the three biotech crops for cultivation which came before the Commission: two insect resistant corn varieties and the starch potato Amflora which had been positively assessed by EFSA years ago.
In Europe, only one biotech crop is available for farmers, an insect-resistant Bt maize. Since 1998 not one single new biotech crop has been allowed to reach the market for cultivation. This stands in stark contrast to the 120 plus products for 23 crops available to farmers worldwide. With such politically motivated steps Europe is holding up a well-established technology and is putting its credibility at risk. The existing EU approval system, which has been agreed upon between the Commission, the Member States and the European Parliament includes a thorough examination involving the scientific assessment of each and every biotech crop and its potential environmental as well as health and safety impact. Europe is still just talking about the technology, while the rest of the world is moving ahead rapidly, causing Europe to become increasingly isolated. "Today's debate at the EU Commission is yet another example of procrastination. The system is in place, and it should be allowed to function," says Bernward Garthoff, Vice Chairman of EuropaBio - the EU association for bioindustries.
"Although we welcome the measures addressed to imports such as the Commission decision to ask Austria to lift its ban on two biotech maizes, and find a technical solution to the issue of low level presence before the summer, we would have expected the Commission to do more for European farmers so that they can actually cultivate more biotech crops and not just import them," says Nathalie Moll, Director of EuropaBio.
Watchlist
This is where you can add this news to your personal favourites
EuropaBio warmly welcomes the European Commission’s new proposal on industrial policy for growth and economic recovery. Launched by Vice President Tajani, following extensive consultation and analysis, the Communication builds on the work of the Lead Market Initiative (LMI) and highlights ... more
In an exciting twist, two companies have been announced as winners of EuropaBio’s Most Innovative Biotech SME Award 2012. Commission Vice President Tajani who presented the award, during the event hosted by Dr. Kay Swinburne MEP at the European Parliament, named both Austrian healthcare bi ... more
The world is thirsty because we are hungry,” notes the United Nations on World Water Day. The world’s population reached 7 billion in 2011, and it is predicted to rise to at least 9 billion by 2050. More people living on our planet will require a more efficient use of dwindling natural res ... more
EuropaBio, the European association for bioindustries, has 35 corporate members and 23 national biotechnology associations representing some 1000 biotech companies in Europe more
EuropaBio is the political voice of the biotechnology industry in Europe. Our association of bioindustries has some 85 corporate and 7 associate members operating worldwide, 5 Bioregions and 25 national biotechnology associations, representing 1800 small and medium sized biotech companies ... more
Cognis announced that the European Food Safety Authority (EFSA) concludes that the safety of Tonalin® CLA has been established for defined uses as a food ingredient. The EFSA scientific opinion marks a major step to gaining novel food approval for Tonalin® CLA in Europe.
Cognis was the fir ... more
The results of a nationwide study coordinated by BfR indicate that Salmonella can frequently be detected in pig breeding stocks. In most cases, however, only a small number of pigs are infected. The study is part of an investigation of pig breeding stocks conducted last year in the European ... more
Methicillin-resistant Staphylococcus aureus (MRSA) are widespread in pig breeding stocks in Germany. The results of a nationwide study by BfR confirm the findings of earlier studies in Germany and other EU Member States. They are part of a study conducted last year in pig breeding stocks in ... more
The European Food Safety Authority (EFSA) is the keystone of European Union (EU) risk assessment regarding food and feed safety. In close collaboration with national authorities and in open consultation with its stakeholders, EFSA provides independent scientific advice and clear communicati ... more